MERCER ISLAND, Wash., May 26, 2021 – CarepathRx, a leader in pharmacy and medication management solutions, announced a new home infusion pharmacy partnership with Allied Health Solutions, part of the West Virginia University Medicine (WVU Medicine) health system. This multi-year agreement will expand patient access to home infusion therapies to include both acute and specialty infusion medications.

As the gateway to post-acute care, hospitals are ideally positioned to leverage existing resources to provide infusion services in the home, whereby optimizing patient care and outcomes. “Our partnership with WVU Medicine expands clinical services beyond their hospital walls and offers a new and unique service to the community” said Keith Crawford, Chief Strategy Officer at CarepathRx. “We are very excited about this partnership. Our turnkey Home Infusion Program will help WVU Medicine build operational capabilities, achieve appropriate compliance and accreditation, and refine transition of care oversight, while providing comprehensive back-office and revenue cycle management.”

WVU Medicine, the affiliated academic medical system of West Virginia University, includes more than 20 hospitals and institutions across West Virginia, Maryland, Ohio, and Pennsylvania.

“Allied Health Solutions, a WVU Medicine company, is proud to partner with CarepathRx to deliver comprehensive infusion services to thousands of patients across our state and the nation,” said Louis Sokos, B.S. Pharm, MBA, Director of Specialty Pharmacy Services at Allied Health Solutions Specialty Pharmacy. “Delivering access to specialty and home infusion not only provides an invaluable addition to our health system, but also creates a cost-effective alternative to receiving treatment in a hospital or clinical setting—a net positive for our patients, their families, and their communities.”

“This is an exciting partnership, and we are proud to be working with WVU Medicine,” said Mark Mikhael, Chief Pharmacy Officer, CarepathRx. “Improving the continuity of care for patients requiring infusion therapies will have a positive impact on patient care and help to reduce the cost associated with this type of medicine.”

The home infusion services offered by WVU Medicine are expected to go live August 1, 2021.

Contact: Keith Crawford/CarepathRx
Mobile: 720 854 5588
E-mail: keith.crawford@carepathrxllc.com

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

MERCER ISLAND, Wash., March 3, 2021 – CarepathRx, a leader in pharmacy and medication management solutions, announced today a new partnership with Ephraim McDowell Regional Medical Center to provide comprehensive home infusion services to their patients and communities in central Kentucky.

The result of this partnership allows Ephraim McDowell to expand their pharmacy capabilities and clinical oversight to improve patient care. “We are excited to partner with Ephraim McDowell,” said Keith Crawford, Chief Strategy Officer at CarepathRx. “Home infusion is a growing aspect in the healthcare delivery system and hospitals play an important role. Most conditions that require infusion therapies are diagnosed in a hospital setting or affiliated physician office. CarepathRx works directly with hospitals to build operational capabilities, achieve appropriate compliance, and accreditation, while providing full-service back-office and revenue cycle management.”

Ephraim McDowell Health is an integrated healthcare provider serving more than 119,000 residents from six counties in Kentucky. At the core of the system is Ephraim McDowell Regional Medical Center, a non-profit, 222-bed licensed hospital in Danville, Ky.

“Ephraim McDowell Health provides a comprehensive, integrated healthcare delivery system, which now includes an exceptional home infusion pharmacy program to meet the growing needs of our patient population,” said Joan Haltom, PharmD, FKSHP, System Director of Pharmacy, Ephraim McDowell Health. “CarepathRx was an indispensable partner throughout the development and implementation of our home infusion pharmacy, and we are excited to welcome our first patients.”

“This is an exciting partnership, and we are happy to be working with Ephraim McDowell,” said Mark Mikhael, Chief Pharmacy Officer at CarepathRx Infusion Solutions. “By managing the home infusion, the patient benefits from improved continuity of care from a provider they know and trust.”

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

This comprehensive partnership fully integrates the pharmacy operations at Knox Community Hospital (KCH)…

MERCER ISLAND, Wash., December 28, 2020 – CarepathRx, a leader in pharmacy and medication management solutions, announced today the formation of CarepathRx Health System Solutions to specifically partner with hospitals and health systems to fully integrate their pharmacy operations, expand healthcare services, improve patient outcomes, and generate new revenue streams.

CarepathRx COO Randy Hyun will lead the Health System Solutions business as CEO, while maintaining his responsibilities with CarepathRx.

CarepathRx transforms health system pharmacies from a cost center into an active revenue generator through a powerful combination of technology, market-leading pharmacy solutions, and wrap-around patient services to include transition of care management, hospital home infusion, specialty pharmacy services, 340B optimization, and telepharmacy assistance. Over 600 hospitals use CarepathRx services that yield over 20M patient-related interactions annually.

“Pharmacy is the only therapy modality that transitions across all treatment domains and has the greatest impact on quality of care, clinical outcomes, and cost control,” said Randy Hyun, CEO of CarepathRx Health System Solutions. “We have all the assets, processes, and programs in place to seamlessly and efficiently implement a truly end-to-end pharmacy solution for our health system partners.”

“The concept of health-system pharmacies operating in multiple domains across healthcare is nothing new – yet it remains elusive. With payment models focusing on value and the quality of care, health systems need to view their pharmacy services as a value adding asset by servicing and monitoring patients across their healthcare journey”, concluded Hyun.

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

Contact: Keith Crawford/CarepathRx
Mobile: 720 854 5588
E-mail: keith.crawford@carepathrxllc.com

MERCER ISLAND, Wash., December 7, 2020 – CarepathRx, a leader in comprehensive pharmacy and medication management solutions for health systems, announced it has helped facilitate the administration of bamlanivimab to a COVID patient in collaboration with one of its Texas Health System partners.

Bamlanivimab is an investigational medicine, developed by Eli Lilly, used for the treatment of COVID-19 in non-hospitalized adults and adolescents 12 years of age or older with mild to moderate symptoms and are at high risk for developing severe COVID-19 symptoms or the need for hospitalization. Bamlanivimab has not been approved but has been authorized for emergency use by FDA.

CarepathRx partners with leading health systems to expand their pharmacy operations to provide fully integrated infusion services and therapies in the home. “As the demand for hospital beds rises with an increase in COVID patients, managing hospital capacity by optimizing patient flow, such as transitioning infusion patients to the home for treatment, becomes critical”, said Keith Crawford, Chief Commercial Officer for CarepathRx. “By having the capabilities to effectively and seamlessly move patients into the home for infusion treatment can have a positive impact on hospital bed capacity”.

According to the FDA, Bamlanivimab has been shown in clinical trials to reduce coronavirus-related hospitalizations. “The drug is designed for those who have contracted the virus and are at a higher risk for developing more severe symptoms, Bamlanivimab is only authorized for patients who meet specific criteria”, said Mark Mikhael, Pharm D, Chief Pharmacy Officer, CarepathRx. “Being able to offer this treatment in a patient’s home may improve access due to increase patient comfort.”

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

Contact: Keith Crawford/CarepathRx
Mobile: 720 854 5588
E-mail: keith.crawford@carepathrxllc.com